Acute Coronary Syndromes - Current and Future Players

1
Acute Coronary Syndromes - Current and Future
Players
One-Stop Shop for Business Information
2
Summary
Acute coronary syndrome (ACS) consists of two
major diseases myocardial infarction (MI) and
unstable angina, with the former being one of the
major killers in the mature markets. Though the
incidence of ACS is either in decline or steady
across the US and European countries, millions of
ACS and suspected ACS patients still visit
emergency rooms every year with symptoms such as
chest pain, and these patients are typically
assessed with in vitro diagnostic cardiac
biomarker tests. Emergence of two pipeline
biomarker tests, Thermo Scientifics copeptin,
and heart-type fatty acid binding protein
(H-FABP), will provide further diagnostic options
to emergency physicians. This report identifies
the unmet needs in the market, provides an
understanding of physician perception of ACS
diagnostic cardiac biomarker testing, and future
trends .
3

• Through Its analysis, it is evident that the ACS
  diagnostic cardiac biomarker testing market is
  dominated by a single player, but it is expected
  that pipeline tests will begin to be used in
  combination with this test. To successfully
  market new diagnostic tests, companies need to
  offer tests that address the current unmet needs
  of current ACS diagnostic cardiac biomarker tests
  and show advantages in combination with tests
  currently in the market. This report will
  identify the opportunities for this technology.
• Scope
• Investigation of current and future market
  competition for ACS diagnostic cardiac biomarker
  testing.
• Competitor assessment.
• - Coverage of key market players and company
  profiles including business description,
  financial overview and SWOT analysis.

4

• - Strategic assessment of the device sector
  through market impact
• analysis, future market scenario and company
  analysis.
• Direct quotes from Key Opinion Leaders (KOL),
  including clinical biochemists, laboratory
  managers, emergency physicians, and cardiologists
  using these diagnostic tests.
• Reasons to buy
• Gain a high level view of the trends shaping and
  driving the ACS diagnostic cardiac biomarker
  testing market.
• Assess competitiveness of products in market by
  understanding the strengths and weaknesses of
  current competition.
• Drive revenues, formulate effective sales and
  marketing strategies and gain in-depth
  understanding of the competitive landscape
• Take a comprehensive look at the markets device
  pipeline and identify promising,
  paradigm-shifting products.

5
Table Of Content

1. Table of Contents
2. Introduction
3. Competitive Assessment
4. Pipeline Products
5. Overview
6. Appendix

6

• To know more
• Acute Coronary Syndromes - Current and Future
  Players

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com